Savant Capital’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-16,083
Closed -$89.1K 1649
2024
Q4
$89.1K Buy
+16,083
New +$89.1K ﹤0.01% 1382